Value and significance of neoadjuvant chemotherapy in the treatment of T1-2N0M0 small cell lung cancer
10.7507/1007-4848.201805054
- VernacularTitle:新辅助化疗对T1～2N0M0 期小细胞肺癌治疗的价值
- Author:
SHAO Weipeng
1
;
WANG Xiaowei
1
;
ZHANG Zhenrong
1
;
LIU Deruo
1
Author Information
1. Department of Thoracic Surgery, Peking University China-Japan Friendship School of Clinical Medicine, China-Japan Friendship Hospital, Beijing, 100029, P.R.China
- Publication Type:Journal Article
- Keywords:
Small cell lung cancer;
neoadjuvant chemotherapy;
surgery
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2019;26(3):278-281
- CountryChina
- Language:Chinese
-
Abstract:
Small cell lung cancer is a pathological type with higher malignancy in lung cancer, and has biological characteristics different from non-small cell lung cancer, such as rapid growth, high malignancy and poor prognosis. Mediastinal lymph node and distant metastasis occur frequently. In recent years, the treatment of limited-stage small cell lung cancer has been stagnant, and various treatments are poor. The operation is mainly suitable for patients with small cell lung cancer (T1-2N0M0). Small cell lung cancer has strong sensitivity to chemotherapy, but the clinical application of neoadjuvant chemotherapy in T1-2N0M0 small cell lung cancer remains controversial. This article reviewed the value of neoadjuvant chemotherapy in the treatment of T1-2N0M0 small cell lung cancer.
